TAGLN2 and pulmonary arterial hypertension: The results indicated that TAGLN2 indirectly promoted PAH progression by regulating cysteinylglycine disulfide and eicosenedioate, with the mediating effects accounting for 3.15% and 5.21% of the total effect, respectively (Table 4).